Resources from the same session
LBA5 - Long-term tolerability of adjuvant osimertinib in patients with resected EGFR-mutated (EGFRm) stage IB–IIIA non-small cell lung cancer (NSCLC) from ADAURA
Presenter: Thomas John
Session: Mini Oral session: Thoracic cancers
Resources:
Abstract
Slides
Webcast
LBA12 - Tumour genomics in patients (pts) with epidermal growth factor receptor-mutated (EGFRm) advanced NSCLC treated with first-line (1L) osimertinib in the phase II ELIOS study
Presenter: Myung-Ju Ahn
Session: Mini Oral session: Thoracic cancers
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA5 and LBA12
Presenter: Alfredo Addeo
Session: Mini Oral session: Thoracic cancers
Resources:
Slides
Webcast